ASCO 2025 – BRCA Variants & Outcomes with Dr. Angela Toss

Dr. Angela Toss reviews findings from an international cohort study presented at ASCO 2025, exploring how different types of BRCA1/2 pathogenic or likely pathogenic variants impact outcomes in young patients with breast cancer.